BON Unveils $18 Million Partnership for Revolutionary Second-Generation Apple Series Health Solutions

Bon Natural Life Limited (NASDAQ: BON), a prominent player in the bio-ingredient sector focusing on natural health and personal care, has made headlines with the announcement of a substantial cooperation agreement worth $18 million. This partnership is with Beijing Huahai Keyuan Technology Co. Ltd., a well-established distributor of health products in China. According to the terms of the agreement, which spans a duration of 24 months, Huahai Keyuan will distribute BON's next-generation Apple Series health products across the Greater China region.

The Apple Series aims to capitalize on the growing consumer interest in effective weight management and metabolic health solutions. Using advanced low-temperature extraction technology, this innovative product line boasts an impressive 80% increase in bioactivity compared to its predecessor, significantly enhancing the extraction efficiency of its active ingredients. The result is a unique formulation that successfully combines powerful apple polyphenols with plant proteins, demonstrating substantial effectiveness in weight management and overall metabolic health.

Over recent decades, protein supplements have evolved into essential components of health and fitness regimens worldwide. They are particularly vital for maintaining immune function, supporting fitness goals, and promoting longevity. BON is diversifying the protein supplement market by integrating clinically proven apple polyphenols, which are known to bolster lipid metabolism and improve body composition while reducing age-associated muscle deterioration. This strategic innovation positions BON's product line at the crossroads of market necessity and groundbreaking functionality, offering significant potential for growth.

Early market feedback has been promising, with similar formulations generating impressive monthly sales figures exceeding $40 million. Experts attribute this financial success to a rising willingness among consumers to invest in science-backed nutraceuticals. The leadership team at BON is confident that their enhanced second-generation offerings will perform exceptionally well, underscoring their competitive market advantages.

Yongwei Hu, the Chairman and CEO of BON, stated, "As a global leader in apple polyphenols, we take on both the responsibility and the capability to develop superior health solutions. Our vertically integrated supply chain — from sourcing raw materials to production — positions us ideally to lead within the burgeoning metabolic health segment. The increased bioactivity of our second-generation apple polyphenols is anticipated to drive remarkable revenue and profit growth across the nutraceutical and functional food sectors, fostering shareholder value and robust returns."

About Bon Natural Life Limited

Bon Natural Life Limited is a Cayman Islands-based enterprise primarily involved in the natural health and personal care industry. To explore more about BON and its offerings, visit www.bnlus.com.

For queries, please reach out to:
Cindy Liu | IR
Email: [email protected]

Safe Harbor Statement: This release contains forward-looking statements which are subject to inherent risks and uncertainties. Actual results may differ due to various factors, as discussed in the Company's reports filed with the Securities and Exchange Commission, available on its website. The Company does not undertake to update any forward-looking statements except as required by securities laws.